Marisa K. Joubert

2.3k total citations · 1 hit paper
30 papers, 1.9k citations indexed

About

Marisa K. Joubert is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Marisa K. Joubert has authored 30 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 19 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Immunology. Recurrent topics in Marisa K. Joubert's work include Protein purification and stability (22 papers), Monoclonal and Polyclonal Antibodies Research (19 papers) and Biosimilars and Bioanalytical Methods (9 papers). Marisa K. Joubert is often cited by papers focused on Protein purification and stability (22 papers), Monoclonal and Polyclonal Antibodies Research (19 papers) and Biosimilars and Bioanalytical Methods (9 papers). Marisa K. Joubert collaborates with scholars based in United States, Netherlands and United Kingdom. Marisa K. Joubert's co-authors include Linda O. Narhi, Jette Wypych, Quanzhou Luo, Vibha Jawa, Ehab M. Moussa, Elizabeth M. Topp, Balakrishnan S. Moorthy, Jainik Panchal, Janice S. Blum and Yasser Nashed-Samuel and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and PLoS ONE.

In The Last Decade

Marisa K. Joubert

30 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunogenicity of Therapeutic Protein Aggregates

2016 411 citations Marisa K. Joubert, Linda O. Narhi et al. Journal of Pharmaceutical Sciences profile →

Peers

Countries citing papers authored by Marisa K. Joubert

Since Specialization

Citations

This map shows the geographic impact of Marisa K. Joubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marisa K. Joubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marisa K. Joubert more than expected).

Fields of papers citing papers by Marisa K. Joubert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marisa K. Joubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marisa K. Joubert. The network helps show where Marisa K. Joubert may publish in the future.

Co-authorship network of co-authors of Marisa K. Joubert

This figure shows the co-authorship network connecting the top 25 collaborators of Marisa K. Joubert. A scholar is included among the top collaborators of Marisa K. Joubert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marisa K. Joubert. Marisa K. Joubert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advancing the implementation of innovative analytical technologies in pharmaceutical manufacturing—Some regulatory considerations 2024 ·Journal of Pharmaceutical Sciences ·Ting Wang, Nina S. Cauchon, (unknown), Marisa K. Joubert, (unknown), Brian Bell, Robert J. Soto, David Semin	2
2	Experimental validation of a parenteral permitted daily exposure value for cleaning-induced degradants from recombinant therapeutic proteins with in vitro immunogenicity assays 2024 ·Journal of Pharmaceutical Sciences ·Joseph R. Cohen, Marisa K. Joubert, Syeda Tabassum, Allyson Capili, (unknown), Cathie Xiang, (unknown), (unknown), (unknown), David G. Dolan, (unknown)	1
3	A Mass Spectrometric Characterization of Light-Induced Modifications in Therapeutic Proteins 2022 ·Journal of Pharmaceutical Sciences ·Zhongqi Zhang, (unknown), (unknown), Nathan H. Joh, Marisa K. Joubert, Jason Richardson, Bhavana Shah, Mats Wikström, Zhaohui Sunny Zhou, Jette Wypych	17
4	Use of In Vitro Human Skin Models to Assess Potential Immune Activation In Response to Biotherapeutic Attributes and Process-related Impurities 2022 ·Journal of Pharmaceutical Sciences ·Joshua M. Tokuda, Jiansong Xie, Vibha Jawa, (unknown), John Ferbas, Nathan H. Joh, Marisa K. Joubert	7
5	State-of-the-art and emerging trends in analytical approaches to pharmaceutical-product commercialization 2022 ·Current Opinion in Biotechnology ·(unknown), Xiaoyan Guan, Marisa K. Joubert, Scott Kuhns, Stephanie Moore, David Semin, Mats Wikström, Jette Wypych, Chetan T. Goudar	4
6	Differential influence on antibody dependent cellular phagocytosis by different glycoforms on therapeutic Monoclonal antibodies 2020 ·Journal of Biotechnology ·Scott Kuhns, Junyan Shu, Cathie Xiang, (unknown), Qingchun Zhang, (unknown), (unknown), (unknown), Marisa K. Joubert	12
7	Glycan engineering reveals interrelated effects of terminal galactose and core fucose on antibody‐dependent cell‐mediated cytotoxicity 2020 ·Biotechnology Progress ·Qingchun Zhang, Marisa K. Joubert, Alla Polozova, (unknown), (unknown), Francis Kinderman, (unknown), (unknown), (unknown), Gregory C. Flynn, Scott Kuhns	13
8	Silicone Oil Particles in Prefilled Syringes With Human Monoclonal Antibody, Representative of Real-World Drug Products, Did Not Increase Immunogenicity in In Vivo and In Vitro Model Systems 2019 ·Journal of Pharmaceutical Sciences ·Nathan H. Joh, Lisa Thomas, (unknown), Alla Verlinsky, (unknown), (unknown), Vibha Jawa, Shawn Cao, Linda O. Narhi, Marisa K. Joubert	25
9	Characterization of Subvisible Particles in Biotherapeutic Prefilled Syringes: The Role of Polysorbate and Protein on the Formation of Silicone Oil and Protein Subvisible Particles After Drop Shock 2019 ·Journal of Pharmaceutical Sciences ·(unknown), Gregory V. Barnett, (unknown), Linda O. Narhi, Nathan H. Joh, Marisa K. Joubert, Shawn Cao	37
10	Impact of Precipitation of Antibody Therapeutics After Subcutaneous Injection on Pharmacokinetics and Immunogenicity 2019 ·Journal of Pharmaceutical Sciences ·Francis Kinderman, (unknown), Vibha Jawa, Marisa K. Joubert, Nathan H. Joh, (unknown), (unknown), Jiansong Xie, John Ferbas, Helen J. McBride	22
11	Chemical and Biophysical Characteristics of Monoclonal Antibody Solutions Containing Aggregates Formed during Metal Catalyzed Oxidation 2017 ·Pharmaceutical Research ·Linda O. Narhi, Quanzhou Luo, Jette Wypych, Riccardo Torosantucci, Andrea Hawe, Kiyoshi Fujimori, Yasser Nashed-Samuel, Vibha Jawa, Marisa K. Joubert, Wim Jiskoot	13
12	Mouse Models for Assessing Protein Immunogenicity: Lessons and Challenges 2016 ·Journal of Pharmaceutical Sciences ·Wim Jiskoot, Grzegorz Kijanka, Theodore W. Randolph, John F. Carpenter, Atanas V. Koulov, Hanns‐Christian Mahler, Marisa K. Joubert, Vibha Jawa, Linda O. Narhi	85
13	Evaluating Immunogenicity Risk Due to Host Cell Protein Impurities in Antibody-Based Biotherapeutics 2016 ·The AAPS Journal ·Vibha Jawa, Marisa K. Joubert, Qingchun Zhang, Meghana Deshpande, (unknown), Michael Hall, Gregory C. Flynn	71
14	Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based Biotherapeutics 2016 ·PLoS ONE ·Marisa K. Joubert, Meghana Deshpande, Jane Yang, (unknown), Christine Bryson, Mark H. Fogg, Matthew Baker, Jonathan Herskovitz, Theresa J. Goletz, Lei Zhou, Michael Moxness, Gregory C. Flynn, Linda O. Narhi, Vibha Jawa	90
15	Structural Characterization of a Monoclonal Antibody–Maytansinoid Immunoconjugate 2015 ·Analytical Chemistry ·Quanzhou Luo, (unknown), Christopher J. Borths, (unknown), Jie Wen, Marisa K. Joubert, Jette Wypych	50
16	Development of a Human Antibody Tolerant Mouse Model to Assess the Immunogenicity Risk Due to Aggregated Biotherapeutics 2013 ·Journal of Pharmaceutical Sciences ·(unknown), Vibha Jawa, Marisa K. Joubert, Arunan Kaliyaperumal, Catherine M. Eakin, (unknown), Oscar Pan, Jilin Sun, Martha Hokom, Theresa J. Goletz, Jette Wypych, Lei Zhou, Bruce A. Kerwin, Linda O. Narhi, Taruna Arora	41
17	T-cell-dependent antibody responses in the rat: Forms and sources of keyhole limpet hemocyanin matter 2013 ·Journal of Immunotoxicology ·Hervé Lebrec, M. Benjamin Hock, John S. Sundsmo, Daniel T. Mytych, (unknown), (unknown), Marisa K. Joubert, (unknown), Liqing Zhou, Jeanine L. Bussiere	13
18	Highly Aggregated Antibody Therapeutics Can Enhance the in Vitro Innate and Late-stage T-cell Immune Responses 2012 ·Journal of Biological Chemistry ·Marisa K. Joubert, Martha Hokom, Catherine M. Eakin, Lei Zhou, Meghana Deshpande, Matthew Baker, Theresa J. Goletz, Bruce A. Kerwin, (unknown), Linda O. Narhi, Vibha Jawa	203
19	Classification and Characterization of Therapeutic Antibody Aggregates 2011 ·Journal of Biological Chemistry ·Marisa K. Joubert, Quanzhou Luo, Yasser Nashed-Samuel, Jette Wypych, Linda O. Narhi	255
20	Chemical Modifications in Therapeutic Protein Aggregates Generated under Different Stress Conditions 2011 ·Journal of Biological Chemistry ·Quanzhou Luo, Marisa K. Joubert, (unknown), Randal R. Ketchem, Linda O. Narhi, Jette Wypych	163

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact